Capello Resigns as PerkinElmer CFO, NextGen Appoints Biomarker Execs, and Others | GenomeWeb
NEW YORK (GenomeWeb News) - PerkinElmer said this week that Jeff Capello has resigned as the company’s CFO, effective June 6, to pursue other interests.
 
Michael Battles will replace Capello on an interim basis. Battles is currently the company’s vice president and controller.
 
Capello joined PerkinElmer in 2001 as controller for the analytical Instruments business. Prior to that, he held several positions at Deloitte & Touche.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.